Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001144204-17-052664
Filing Date
2017-10-16
Accepted
2017-10-16 17:24:09
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM F-1 tv476902_f1.htm F-1 377258
2 EXHIBIT 3.1 tv476902_ex3-1.htm EX-3.1 163844
3 EXHIBIT 5.1 tv476902_ex5-1.htm EX-5.1 18227
4 EXHIBIT 23.1 tv476902_ex23-1.htm EX-23.1 2640
5 GRAPHIC tv476902_img1.jpg GRAPHIC 13583
6 GRAPHIC tv476902_ex5-1img01.jpg GRAPHIC 10709
7 GRAPHIC tv476902_ex5-1img03.jpg GRAPHIC 62620
8 GRAPHIC tv476902_ex5-1img02.jpg GRAPHIC 3312
  Complete submission text file 0001144204-17-052664.txt   687836
Mailing Address 10 PLAUT STREET, SCIENCE PARK POB 4059 REHOVOT L3 76706
Business Address 10 PLAUT STREET, SCIENCE PARK POB 4059 REHOVOT L3 76706 972-73-222-0700
Rosetta Genomics Ltd. (Filer) CIK: 0001362959 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-220985 | Film No.: 171139427
SIC: 2834 Pharmaceutical Preparations